Analyze Diet
Equine veterinary journal2015; 48(4); 472-478; doi: 10.1111/evj.12450

Lamellar pathology in horses with pituitary pars intermedia dysfunction.

Abstract: Hoof lamellar pathology in horses with pituitary pars intermedia dysfunction (PPID) has not been described previously. Objective: To describe the histomorphometry and pathological lesions in hoof lamellar tissue of animals that had PPID with or without concurrent laminitis, with reference to age-matched controls. We hypothesised that lamellar lesions consistent with laminitis would be associated with PPID, even in animals without current or historical laminitis. Methods: Prospective case-control study. Methods: Mid-dorsal hoof histological sections were obtained post mortem from the forelimbs of 16 PPID-affected animals either with (n = 6) or without laminitis (n = 10) and 10 age- and breed-matched controls. Sections were examined by a blinded veterinary pathologist. The length and width of 10 primary epidermal lamellae were measured using image analysis software. The morphology and pathology of primary and secondary epidermal lamellae were then typed or graded in axial, middle and abaxial regions. Fasting serum insulin, plasma adrenocorticotropin and blood glucose concentration were measured from blood samples taken prior to euthanasia. Results: All animals with PPID and laminitis had fasting hyperinsulinaemia (median 74.1 miu/l, interquartile range 49.9-349.5 miu/l) whereas PPID animals without laminitis had serum insulin concentrations below the upper limit of the reference range (<20 miu/l). Lamellar pathology in PPID animals with laminitis was variable in severity and unrelated to the reported duration of laminitis (range 2 months-5 years). Most lesions were located abaxially within the lamellar tissue and included increased length and width of the lamellae, chronic abnormal keratinisation, interlamellar epidermal bridging and cell death with more acute lamellar tearing in some cases. The lamellae of PPID animals without laminitis were normal referent to the relevant control group. Conclusions: Whether PPID and hyperinsulinaemia have a causal inter-relationship or not, it may only be the hyperinsulinaemia that is associated with lamellar morphological alteration and pathology consistent with laminitis.
Publication Date: 2015-06-04 PubMed ID: 25869529DOI: 10.1111/evj.12450Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study investigated the pathological changes in the hoof lamellar tissues of horses with Pituitary Pars Intermedia Dysfunction (PPID) that may or may not have concurrent laminitis, in comparison with age-matched controls. The results suggest that hyperinsulinaemia (abnormally high levels of insulin in the blood) may be associated with alterations and damage in the hoof lamellae indicative of laminitis.

Research Methodology

  • The research study adopted a prospective case-control methodology.
  • Hoof histological samples were obtained from the mid-dorsal sections post-mortem of 16 horses that had PPID. Some of these horses had concurrent laminitis (n=6) while others did not (n=10).
  • An additional 10 similarly aged and bred horses without PPID were included as controls.
  • All hoof sections were examined by a veterinary pathologist who was not privy to the information about the horses. Measurements of the length and width of 10 primary epidermal lamellae were taken using image analysis software.
  • The morphology and any pathological variations of the primary and secondary epidermal lamellae were characterized and graded in different hoof regions.
  • Prior to euthanasia, blood samples were taken from the horses to measure fasting serum insulin, plasma adrenocorticotropin, and blood glucose concentration.

Research Findings

  • All the PPID horses which had laminitis also had abnormally high levels of insulin (hyperinsulinaemia), compared to PPID horses without laminitis, who had insulin within the reference range.
  • In PPID horses with laminitis, the lamellar pathology varied in severity and did not correlate with the reported periods of laminitis. The abnormalities were mainly located at the furthest area of the lamellar tissue and involved abnormal lengthening and widening of the lamellae, abnormal buildup of keratin, the formation of cellular bridges between lamellae, and cellular death. In some cases, there were also more severe damages including lamellar tearing.
  • The lamellae of PPID horses without laminitis showed no abnormalities compared to the control group.

Research Conclusion

  • The study suggests that the PPID condition on its own and hyperinsulinaemia may not have a causal inter-relationship. Rather, the pathological changes consistent with laminitis in the hoof lamellae may be strongly associated with hyperinsulinaemia.

Cite This Article

APA
Karikoski NP, Patterson-Kane JC, Singer ER, McFarlane D, McGowan CM. (2015). Lamellar pathology in horses with pituitary pars intermedia dysfunction. Equine Vet J, 48(4), 472-478. https://doi.org/10.1111/evj.12450

Publication

ISSN: 2042-3306
NlmUniqueID: 0173320
Country: United States
Language: English
Volume: 48
Issue: 4
Pages: 472-478

Researcher Affiliations

Karikoski, N P
  • Department of Equine and Small Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Helsinki, Finland.
Patterson-Kane, J C
  • Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Singer, E R
  • Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
McFarlane, D
  • Department of Physiological Sciences, Center for Veterinary Health Sciences, Oklahoma State University, Stillwater, Oklahoma, USA.
McGowan, C M
  • Institute of Ageing and Chronic Disease, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.

MeSH Terms

  • Animals
  • Case-Control Studies
  • Female
  • Foot Diseases / etiology
  • Foot Diseases / pathology
  • Foot Diseases / veterinary
  • Hoof and Claw / pathology
  • Horse Diseases / etiology
  • Horse Diseases / pathology
  • Horses
  • Inflammation / etiology
  • Inflammation / pathology
  • Inflammation / veterinary
  • Male
  • Pituitary Diseases / complications
  • Pituitary Diseases / pathology
  • Pituitary Diseases / veterinary
  • Pituitary Gland, Intermediate / pathology

Citations

This article has been cited 14 times.
  1. de Tonnerre DJ, Medina Torres CE, Stefanovski D, Robinson MA, Kemp KL, Bertin FR, van Eps AW. Effect of sirolimus on insulin dynamics in horses.. J Vet Intern Med 2023 Mar;37(2):703-712.
    doi: 10.1111/jvim.16650pubmed: 36840433google scholar: lookup
  2. Stoeckle SD, Timmermann D, Merle R, Gehlen H. Plasma Amino Acid Concentration in Obese Horses with/without Insulin Dysregulation and Laminitis.. Animals (Basel) 2022 Dec 18;12(24).
    doi: 10.3390/ani12243580pubmed: 36552500google scholar: lookup
  3. Drozdzewska K, Gehlen H. Markers for internal neoplasia in the horse.. Vet Med Sci 2023 Jan;9(1):132-143.
    doi: 10.1002/vms3.1042pubmed: 36495211google scholar: lookup
  4. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.. Vet Sci 2022 Oct 10;9(10).
    doi: 10.3390/vetsci9100556pubmed: 36288169google scholar: lookup
  5. Nitzsche AM, Fey K, Büttner K, Gröf M, Staszyk C. The Gingiva of Horses With Pituitary Pars Intermedia Dysfunction: A Macroscopic Anatomical Evaluation.. Front Vet Sci 2021;8:786971.
    doi: 10.3389/fvets.2021.786971pubmed: 35146012google scholar: lookup
  6. Sillence M, Meier A, de Laat M, Klee R, Reiche D. Demographic, morphologic, hormonal and metabolic factors associated with the rate of improvement from equine hyperinsulinaemia-associated laminitis.. BMC Vet Res 2022 Jan 18;18(1):49.
    doi: 10.1186/s12917-022-03149-zpubmed: 35042535google scholar: lookup
  7. Stokes SM, Stefanovski D, Bertin FR, Medina-Torres CE, Belknap JK, van Eps AW. Plasma amino acid concentrations during experimental hyperinsulinemia in 2 laminitis models.. J Vet Intern Med 2021 May;35(3):1589-1596.
    doi: 10.1111/jvim.16095pubmed: 33704816google scholar: lookup
  8. Watts MR, Hegedus OC, Eades SC, Belknap JK, Burns TA. Association of sustained supraphysiologic hyperinsulinemia and inflammatory signaling within the digital lamellae in light-breed horses.. J Vet Intern Med 2019 May;33(3):1483-1492.
    doi: 10.1111/jvim.15480pubmed: 30912229google scholar: lookup
  9. de Laat MA, Sillence MN, Reiche DB. Phenotypic, hormonal, and clinical characteristics of equine endocrinopathic laminitis.. J Vet Intern Med 2019 May;33(3):1456-1463.
    doi: 10.1111/jvim.15419pubmed: 30697823google scholar: lookup
  10. Cassimeris L, Engiles JB, Galantino-Homer H. Detection of endoplasmic reticulum stress and the unfolded protein response in naturally-occurring endocrinopathic equine laminitis.. BMC Vet Res 2019 Jan 10;15(1):24.
    doi: 10.1186/s12917-018-1748-xpubmed: 30630474google scholar: lookup
  11. Meier A, Reiche D, de Laat M, Pollitt C, Walsh D, Sillence M. The sodium-glucose co-transporter 2 inhibitor velagliflozin reduces hyperinsulinemia and prevents laminitis in insulin-dysregulated ponies.. PLoS One 2018;13(9):e0203655.
    doi: 10.1371/journal.pone.0203655pubmed: 30212530google scholar: lookup
  12. Lewis SL, Holl HM, Long MT, Mallicote MF, Brooks SA. Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population.. PLoS One 2018;13(7):e0200583.
    doi: 10.1371/journal.pone.0200583pubmed: 30001422google scholar: lookup
  13. Morgan RA, Keen JA, Walker BR, Hadoke PW. Vascular Dysfunction in Horses with Endocrinopathic Laminitis.. PLoS One 2016;11(9):e0163815.
    doi: 10.1371/journal.pone.0163815pubmed: 27684374google scholar: lookup
  14. Morgan R, Keen J, McGowan C. Equine metabolic syndrome.. Vet Rec 2015 Aug 15;177(7):173-9.
    doi: 10.1136/vr.103226pubmed: 26273009google scholar: lookup